https://www.livemint.com/market/stock-market-news/biocon-q4-results-consolidated-pat-up-by-31-ebitda-strong-growth-dividend-key-highlights-here-11684854252412.html
0
0
5/23/23 at 3:07pm
Organization
Livemint
Author
Pooja Sitaram Jaiswar
Biocon posted double-digit growth across key parameters in the March 2023 quarter. The pharma major also declared a dividend of 30% for its shareholders for the fiscal year FY23.
Create an account
or login to join the discussion